Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

More severe alopecia areata can lower quality of life.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Low-Level Light Therapy improves quality of life more for women than men with hair loss.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

A new mouse gene, Keratin 17n, is mainly found in nail tissue and may explain why mice without Keratin 17 don't have nail issues.

25% of women in North Sudan have traction alopecia, linked to family history and hair treatments, highlighting the need for better hair care awareness.

There is a significant need for better-validated quality of life tools in dermatology.

Indian herbal medicine shows promise for treating skin diseases but needs more research to prove effectiveness.

Hair loss is common in Jazan, affecting more women, and skin diseases significantly impact mental health.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.